Since liver metastasis is the leading cause of CRC patient death, understanding the mechanisms underlying WTX loss driven liver metastasis has potential to vastly improving the survival rate of CRC patients by preventing CRC progression. This evidence concerns the gene AMER1 and colorectal carcinoma.